About Webster Santos
Form D filings for S1P Therapeutics in 2023 list Webster Santos as executive officer and director.
Webster Santos first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Webster Santos in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Webster Santos works with at each company, as listed on that company's latest Form D.
S1P Therapeutics Inc. · Form D, Jun 9, 2023
KL
Kevin Lynch
Executive officer and director
RS
Ronald Sayco
Chief Executive Officer and director